Adartrel gets CHMP positive opinion

The EMEA's CHMP issued a positive opinion to GlaxoSmithKline (LSE:GSK; GSK) for Adartrel ropinirole to treat moderate to severe idiopathic restless legs syndrome (RLS). The dopamine D2 and D3 receptor...